Regencell Bioscience Holdings Limited (RGC)

USD 28.21

(-7.48%)

Total Debt Summary of Regencell Bioscience Holdings Limited

  • Regencell Bioscience Holdings Limited's latest annual total debt in 2024 was 59.8 Thousand USD , down -81.51% from previous year.
  • Regencell Bioscience Holdings Limited's latest quarterly total debt in 2024 Q4 was 59.8 Thousand USD , down 0.0% from previous quarter.
  • Regencell Bioscience Holdings Limited reported annual total debt of 463.66 Thousand USD in 2023, down -39.88% from previous year.
  • Regencell Bioscience Holdings Limited reported annual total debt of 771.25 Thousand USD in 2022, down -79.05% from previous year.
  • Regencell Bioscience Holdings Limited reported quarterly total debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Regencell Bioscience Holdings Limited reported quarterly total debt of 59.8 Thousand USD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Regencell Bioscience Holdings Limited (2024 - 2002)

Created with Highcharts 11.1.0YearsTotal Debt2002200420062008201020122014201620182020202220240 USD500000000 USD1000000000 USD1500000000 USD2000000000 USD2500000000 USD3000000000 USD

Historical Annual Total Debt of Regencell Bioscience Holdings Limited (2024 - 2002)

Year Total Debt Total Debt Growth
2024 59.8 Thousand USD -81.51%
2023 463.66 Thousand USD -39.88%
2022 771.25 Thousand USD -79.05%
2021 3.68 Million USD 19.94%
2020 3.06 Million USD 47.46%
2019 2.08 Million USD -99.91%
2018 2.36 Billion USD 6.45%
2017 2.22 Billion USD -1.47%
2016 2.25 Billion USD -0.43%
2015 2.26 Billion USD 0.0%
2013 2.21 Billion USD 14.64%
2012 1.93 Billion USD -2.96%
2011 1.99 Billion USD 4.39%
2010 1.9 Billion USD 1140.06%
2009 154 Million USD 0.0%
2007 1.86 Billion USD -0.9%
2006 1.88 Billion USD -0.53%
2005 1.89 Billion USD 75.58%
2004 1.07 Billion USD 0.0%
2002 561 Million USD 0.0%

Peer Total Debt Comparison of Regencell Bioscience Holdings Limited

Name Total Debt Total Debt Difference
Intra-Cellular Therapies, Inc. 16.93 Million USD 99.647%
PainReform Ltd. 86 Thousand USD 30.457%
Alvotech 1.07 Billion USD 99.994%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.991%
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.981%
Aquestive Therapeutics, Inc. 98.82 Million USD 99.939%
Journey Medical Corporation 17.73 Million USD 99.663%
Dynavax Technologies Corporation 256.91 Million USD 99.977%
Esperion Therapeutics, Inc. 540.94 Million USD 99.989%
Bright Green Corporation 1.85 Million USD 96.77%
Pacira BioSciences, Inc. 586.04 Million USD 99.99%
Embecta Corp. 1.63 Billion USD 99.996%
Sunshine Biopharma, Inc. 657.7 Thousand USD 90.907%
Sunshine Biopharma, Inc. 657.7 Thousand USD 90.907%
SCYNEXIS, Inc. 15.08 Million USD 99.603%
Petros Pharmaceuticals, Inc. 8.27 Million USD 99.277%
Silver Spike Investment Corp. - USD -Infinity%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 97.741%
Alpha Teknova, Inc. 30.45 Million USD 99.804%
Safety Shot Inc 1.54 Million USD 96.139%
Procaps Group, S.A. 285.93 Million USD 99.979%
Cosmos Health Inc. 12.42 Million USD 99.519%
Theratechnologies Inc. 58.96 Million USD 99.899%
Harrow Health, Inc. 190.5 Million USD 99.969%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD 90.163%
Biofrontera Inc. 5.39 Million USD 98.892%
DURECT Corporation 20.74 Million USD 99.712%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 99.856%
Cronos Group Inc. 2.53 Million USD 97.645%
OptiNose, Inc. 131.74 Million USD 99.955%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.992%
Kala Pharmaceuticals, Inc. 36.32 Million USD 99.835%
RedHill Biopharma Ltd. 1.17 Million USD 94.901%
Organogenesis Holdings Inc. 119.35 Million USD 99.95%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 99.675%
Radius Health, Inc. 365.31 Million USD 99.984%
Universe Pharmaceuticals INC 5.48 Million USD 98.909%
ProPhase Labs, Inc. 21.38 Million USD 99.72%
Phibro Animal Health Corporation 525.45 Million USD 99.989%
Procaps Group S.A. 285.93 Million USD 99.979%
TherapeuticsMD, Inc. 8 Million USD 99.253%
Viatris Inc. 18.12 Billion USD 100.0%
Rockwell Medical, Inc. 13.43 Million USD 99.555%
Aytu BioPharma, Inc. 15.12 Million USD 99.605%
SIGA Technologies, Inc. 1.46 Million USD 95.915%
Tilray Brands, Inc. 387.31 Million USD 99.985%
Lifecore Biomedical, Inc. 130.36 Million USD 99.954%
Shineco, Inc. 29.65 Million USD 99.798%
PetIQ, Inc. 468.3 Million USD 99.987%
Incannex Healthcare Limited 373 Thousand USD 83.966%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.986%
Alimera Sciences, Inc. 67.39 Million USD 99.911%
Assertio Holdings, Inc. 40.91 Million USD 99.854%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD 94.501%
Clever Leaves Holdings Inc. 2.08 Million USD 97.134%
Cyclo Therapeutics, Inc. 1.03 Million USD 94.211%
Avadel Pharmaceuticals plc 35.38 Million USD 99.831%
Hempacco Co., Inc. 13.72 Million USD 99.564%
Talphera, Inc. - USD -Infinity%
Alvotech 1.07 Billion USD 99.994%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 99.904%
Lantheus Holdings, Inc. 616.94 Million USD 99.99%
Currenc Group, Inc. 31.94 Million USD 99.813%
Kamada Ltd. 8.74 Million USD 99.316%
Indivior PLC 281.6 Million USD 99.979%
Evoke Pharma, Inc. 5 Million USD 98.804%
Flora Growth Corp. 3.67 Million USD 98.371%
Cyclo Therapeutics, Inc. 1.03 Million USD 94.211%
Evolus, Inc. 126.54 Million USD 99.953%
HUTCHMED (China) Limited 86.13 Million USD 99.931%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.99%
Akanda Corp. 3.99 Million USD 98.504%